KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares Issued
Ratios

Jazz Pharmaceuticals (JAZZ) Shares Outstanding (2016 - 2023)

Historic Shares Outstanding for Jazz Pharmaceuticals (JAZZ) over the last 15 years, with Q2 2023 value amounting to $63.4 million.

  • Jazz Pharmaceuticals' Shares Outstanding rose 123.76% to $63.4 million in Q2 2023 from the same period last year, while for Jun 2023 it was $63.4 million, marking a year-over-year increase of 123.76%. This contributed to the annual value of $63.2 million for FY2022, which is 256.52% up from last year.
  • Jazz Pharmaceuticals' Shares Outstanding amounted to $63.4 million in Q2 2023, which was up 123.76% from $64.0 million recorded in Q1 2023.
  • In the past 5 years, Jazz Pharmaceuticals' Shares Outstanding registered a high of $64.0 million during Q1 2023, and its lowest value of $55.4 million during Q1 2020.
  • Over the past 5 years, Jazz Pharmaceuticals' median Shares Outstanding value was $59.0 million (recorded in 2019), while the average stood at $59.3 million.
  • In the last 5 years, Jazz Pharmaceuticals' Shares Outstanding plummeted by 629.25% in 2019 and then soared by 1041.16% in 2021.
  • Over the past 5 years, Jazz Pharmaceuticals' Shares Outstanding (Quarter) stood at $56.1 million in 2019, then grew by 0.06% to $56.2 million in 2020, then grew by 9.72% to $61.6 million in 2021, then grew by 2.57% to $63.2 million in 2022, then rose by 0.29% to $63.4 million in 2023.
  • Its last three reported values are $63.4 million in Q2 2023, $64.0 million for Q1 2023, and $63.2 million during Q4 2022.